Citation(s)
- Bangash SJ, Green WH, Dolson DJ, Cognetta AB Jr
Eruptive postoperative squamous cell carcinomas exhibiting a pathergy-like reaction around surgical wound sites. J Am Acad Dermatol. 2009 Nov;61(5):892-7. doi: 10.1016/j.jaad.2009.01.037. Epub 2009 Sep 18.
- Kim C, Ko CJ, Leffell DJ
Cutaneous squamous cell carcinomas of the lower extremity: a distinct subset of squamous cell carcinomas. J Am Acad Dermatol. 2014 Jan;70(1):70-4. doi: 10.1016/j.jaad.2013.09.026. Epub 2013 Nov 5.
- Kraus S, Miller BH, Swinehart JM, Shavin JS, Georgouras KE, Jenner DA, Griffin E, Korey A, Orenberg EK
Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1998 Mar;38(3):438-42. doi: 10.1016/s0190-9622(98)70502-x.
- Love WE, Bernhard JD, Bordeaux JS
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol. 2009 Dec;145(12):1431-8. doi: 10.1001/archdermatol.2009.291.
- Metterle L, Nelson C, Patel N
Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review. J Am Acad Dermatol. 2016 Mar;74(3):552-7. doi: 10.1016/j.jaad.2015.09.040. Epub 2015 Nov 11.
- Moore AY
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat. 2009;20(6):328-35. doi: 10.3109/09546630902789326.
- Morse LG, Kendrick C, Hooper D, Ward H, Parry E
Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil. Dermatol Surg. 2003 Nov;29(11):1150-3; discussion 1153. doi: 10.1046/j.1524-4725.2003.29355.x.
- Munday WR, Leffell DJ, McNiff JM, Ko CJ
Histopathologic features of multiple cutaneous squamous cell carcinomas of the lower extremity. J Cutan Pathol. 2016 Sep;43(9):759-65. doi: 10.1111/cup.12738. Epub 2016 Jun 14.
- Peris K, Micantonio T, Fargnoli MC, Lozzi GP, Chimenti S
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol. 2006 Aug;55(2):324-7. doi: 10.1016/j.jaad.2006.04.004.
- Reisinger DM, Cognetta AB Jr, Pynes LT, Paredes AA Jr, Sweeney TJ, Dolson DJ
Treatment of a giant squamous cell carcinoma on the dominant thumb with intralesional 5-fluorouracil. J Am Acad Dermatol. 2011 Jul;65(1):219-21. doi: 10.1016/j.jaad.2009.11.017. No abstract available.
- Solus JF, Murphy GF, Kraft S
Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features. Int J Surg Pathol. 2016 Feb;24(1):29-36. doi: 10.1177/1066896915599058. Epub 2015 Aug 10.
Phase I, Dual Arm, Open-Label, Trial of Intralesional 5-Fluorouracil (5FU) and Intralesional 5FU Combined With Topical Imiquimod in Patients With Squamous Cell Carcinoma (SCC) of the Lower Extremities
Details for clinical trial NCT03370406
